Articles with public access mandates - Vishal AgrawalLearn more
Not available anywhere: 1
Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9. 1, CYP2C9. 2, and CYP2C9. 3
M Subramanian, V Agrawal, D Sandee, HK Tam, WL Miller, TS Tracy
Pharmacogenetics and genomics 22 (8), 590-597, 2012
Mandates: US National Institutes of Health
Available somewhere: 11
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19
V Agrawal, N Huang, WL Miller
Pharmacogenetics and genomics 18 (7), 569-576, 2008
Mandates: US National Institutes of Health
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase.
V Agrawal, JH Choi, KM Giacomini, WL Miller
Pharmacogenetics and genomics 20 (10), 611-618, 2010
Mandates: US National Institutes of Health
Consequences of POR mutations and polymorphisms
WL Miller, V Agrawal, D Sandee, MK Tee, N Huang, JH Choi, K Morrissey, ...
Molecular and cellular endocrinology 336 (1), 174-179, 2011
Mandates: US National Institutes of Health
P450 oxidoreductase deficiency–a new form of congenital adrenal hyperplasia
CE Flück, A Pandey, N Huang, V Agrawal, W Miller
Karger Publishers 13, 67-81, 2008
Mandates: Swiss National Science Foundation
Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency
LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ...
The Journal of Clinical Endocrinology & Metabolism 94 (1), 89-95, 2009
Mandates: US National Institutes of Health
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
D Sandee, K Morrissey, V Agrawal, HK Tam, MA Kramer, TS Tracy, ...
Pharmacogenetics and genomics 20 (11), 677-686, 2010
Mandates: US National Institutes of Health
Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients
T Sahakitrungruang, N Huang, MK Tee, V Agrawal, WE Russell, P Crock, ...
The Journal of Clinical Endocrinology & Metabolism 94 (12), 4992-5000, 2009
Mandates: US National Institutes of Health
Genetic variation in human P450 oxidoreductase
WL Miller, N Huang, V Agrawal, KM Giacomini
Molecular and cellular endocrinology 300 (1), 180-184, 2009
Mandates: US National Institutes of Health
The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency
LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ...
The Journal of Clinical Endocrinology & Metabolism 93 (7), 2913-2916, 2008
Mandates: US National Institutes of Health
COVID‑19 pandemic: Understanding the emergence, pathogenesis and containment
MK Parvez, RM Jagirdar, RS Purty, SK Venkata, V Agrawal, J Kumar, ...
World Academy of Sciences Journal 2 (5), 1-1, 2020
Mandates: Wellcome Trust/DBT India Alliance, Wellcome Trust
Molecular insights into effector binding by DgoR, a GntR/FadR family transcriptional repressor of D‐galactonate metabolism in Escherichia coli
G Arya, M Pal, M Sharma, B Singh, S Singh, V Agrawal, R Chaba
Molecular Microbiology, 2020
Mandates: Department of Biotechnology, India, Department of Science & Technology, India
Publication and funding information is determined automatically by a computer program